Lakefront Biotherapeutics (LKFT) Asset Utilization Ratio (2016 - 2026)

Lakefront Biotherapeutics (LKFT) has 11 years of Asset Utilization Ratio data on file, last reported at 0.31 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.31, up 389.87% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.31 (up 389.87% YoY), and the FY2025 annual result was 0.31, up 377.44% from the prior year.
• Asset Utilization Ratio eased to 0.31 in Q1 2026 per LKFT's latest filing, from 0.32 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.32 in Q4 2025 and troughed at 0.04 in Q1 2023.
• A 5-year average of 0.13 and a median of 0.08 in 2025 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio plunged 64.73% in 2024, then soared 451.69% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2022, then surged by 162.75% to 0.16 in 2023, then sank by 64.73% to 0.06 in 2024, then soared by 451.69% to 0.32 in 2025, then decreased by 3.67% to 0.31 in 2026.
• Business Quant data shows LKFT's Asset Utilization Ratio at 0.31 in Q1 2026, 0.32 in Q4 2025, and 0.07 in Q3 2025.